Skip to content

ICU Medical ICUI Free cash flow

Free cash flow at other companies

Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
-$21.16M-27.6%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$24.67M+26.5%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$546M
TFX
TeleflexTFX
$27.87M+676%
Edwards Lifesciences logo
Edwards LifesciencesEW
-$21.1M-109%
Moog logo
MoogMOG.A

Other financials

Income statement

See full
Revenue$530.2M-12.3%
Gross profit$206.2M-1.8%
Operating income$13.6M+5.4%
Net income$30.1M+295%
EPS (diluted)$1.20+290%

Balance sheet

See full
Cash & equivalents$288.3M-0.5%
Total debt$1.4B-17.5%
Total equity$2.1B+6.3%
Total assets$4.0B-4.1%

Cash flow

See full
Operating cash flow$38.9M-24.2%
CapEx$11.3M-22.7%

Valuation

See full
Market cap$3.51B-6.3%
Enterprise value$4.58B-10.6%
P/E75.3×+70.9×
P/S1.6×+0.1×

Profitability

See full
Gross margin37.9%+2.8pp
Operating margin2%-0.7pp
Net margin-0.3%-0.2pp
FCF margin4.2%-1.2pp

Returns & leverage

See full
Return on equity-0.4%-0.2pp
Debt / equity0.6×-0.2×
Current ratio2.3×-0.3×

Where this comes from

Calculated from ICU Medical’s reported figures.

The official record: ICU Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ICU Medical's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ICU Medical's free cash flow?
ICU Medical (ICUI) reported free cash flow of $27.61M in Q1 2026.
How has ICU Medical's free cash flow changed year-over-year?
ICU Medical's free cash flow decreased by 24.8% year-over-year, from $36.71M to $27.61M.
What is the long-term trend for ICU Medical's free cash flow?
Over 3 years (2021 to 2025), ICU Medical's free cash flow has grown at a -20.4% compound annual growth rate (CAGR), from $199M to $100.29M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.